Brand-name drugs are not clinically superior to their generic counterparts
Wednesday, December 3, 2008 - 02:49
in Health & Medicine
Contrary to the perception of some patients and physicians, there is no evidence that brand-name drugs are clinically superior to their generic counterparts, according to an article in the 3 December issue of JAMA, which examined studies comparing the effectiveness of generic vs. brand-name drugs for treating cardiovascular diseases...
Read the whole article on Science Centric
More from Science Centric
Related
- Brand-name drugs do not appear superior to generic drugs for treating cardiovascular diseasesTue, 2 Dec 2008, 17:23:13 EST
- Generics less effective/safe than branded medications in treating LUTSSun, 26 Apr 2009, 1:38:51 EDT
- First generation antipsychotic drugs as effective as newer ones in some childrenMon, 15 Sep 2008, 5:36:20 EDT
- Guidelines for treating patients with cardiovascular disease often based on weaker evidenceWed, 25 Feb 2009, 7:53:14 EST
- New kids on the block: Latecomers must be unique to outperform pioneer brandsTue, 14 Oct 2008, 13:42:25 EDT